申请人:BASF Aktiengesellschaft
公开号:US04618622A1
公开(公告)日:1986-10-21
Sulfonates of hydroxycoumarins of the formula I ##STR1## where R.sup.1 and R.sup.2 are identical or different and are each hydrogen, halogen or alkyl of 1 to 5 carbon atoms which can be substituted by --NR.sup.4 R.sup.5, --OR.sup.4 or --OC(O)R.sup.4, where R.sup.4 and R.sup.5 are identical or different and are each hydrogen or alkyl of 1 to 4 carbon atoms, or R.sup.1 and R.sup.2 are each a carboxylic acid group --OC(O)R.sup.4 or a carboxamido radical, with the proviso that R.sup.1 is not methyl when R.sup.2 is hydrogen, or R.sup.1 and R.sup.2 together form a --(CH.sub.2).sub.n -- chain where n is 3-5, and R.sup.3 is a straight-chain or branched alkyl radical of 1 to 8 carbon atoms or cycloalkyl of 3 to 8 carbon atoms, each of which can be substituted by halogen, --OR.sup.4, --NR.sup.4 R.sup.5, --CN or phenyl, or R.sup.3 is a straight-chain or branched alkenyl radical of 3 to 8 carbon atoms, an amino group -- NR.sup.4 R.sup.5, or phenyl or naphthyl, each of which is unsubstituted or monosubstituted or polysubstituted by --OR.sup.4, --NR.sup.4 R.sup.5, --NO.sub.2, halogen, --SR.sup.4, --S(O)R.sup.4, --OS(O)R.sup.4, --SCF.sub.3, --OS(O)CF.sub.3, --CN, --C(O)R.sup.4, --OC(O)R.sup.4, --NHC(O)R.sup.4, --CF.sub.3, C.sub.1 -C.sub.4 -alkyl or a combination of these substituents, a process for their preparation, drugs containing these compounds, and compounds of the formula I, in which R.sup.1 is methyl and R.sup.2 is hydrogen, for use as drugs.
化学式为I的羟基香豆素磺酸盐,其中R1和R2相同或不同,分别为氢、卤素或1至5个碳原子的烷基,可以通过—NR4R5、—OR4或—OC(O)R4取代,其中R4和R5相同或不同,分别为氢或1至4个碳原子的烷基,或者R1和R2分别为羧酸基—OC(O)R4或羧酰胺基团,但R1不为甲基时,R2为氢,或R1和R2一起形成—(CH2)n—链,其中n为3-5,R3为1至8个碳原子的直链或支链烷基或3至8个碳原子的环烷基,每个基团可以通过卤素、—OR4、—NR4R5、—CN或苯基取代,或者R3为3至8个碳原子的直链或支链烯基基团、氨基团—NR4R5或苯基或萘基,每个基团均未取代或单取代或多取代,取代基为—OR4、—NR4R5、—NO2、卤素、—SR4、—S(O)R4、—OS(O)R4、—SCF3、—OS(O)CF3、—CN、—C(O)R4、—OC(O)R4、—NHC(O)R4、—CF3、C1-C4-烷基或这些取代基的组合,以及制备这些化合物的方法、含有这些化合物的药物和化学式I中R1为甲基且R2为氢的化合物用作药物。